National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 6894 cases where Vaccine is HPV4 and Serious

Case Details

This is page 27 out of 690

Result pages: prev   18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36   next


VAERS ID: 294477 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Female  
Location: Unknown  
Vaccinated:2007-10-03
Onset:2007-10-08
   Days after vaccination:5
Submitted: 2007-10-11
   Days after onset:3
Entered: 2007-10-25
   Days after submission:14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / SANOFI PASTEUR B5704 / UNK RA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0515U / 1 LA / IM

Administered by: Private       Purchased by: Public
Symptoms: Contusion, Full blood count normal, Menorrhagia, Platelet count decreased, Prothrombin time prolonged
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Accidents and injuries (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PPD, Desogen, Cipro-day of vaccination
Current Illness: resolving diarrheal illness
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CBC wnl, Platelets 30,000, PT13.4. Peripheral smear-wnl except platelets estimated 20,000 LABS: initial plts 30,000 & dropped to low of 8,000, H/H 13.5/41.1.
CDC Split Type:

Write-up: Bruises and extended menses beginning 10/08/07. 1/11/08 Reviewed medical records & vax records included confirm dose & lot #s as reported. Patient experienced diarrhea & abdominal cramps in early 10/07 & stool c/s w/many WBCs & RBCs. Dx w/probable bacterial infection & tx w/oral antibiotics. Felt much better & diarrhea improved. UA w/glucosuria. HbA1C 6.4. Returned to clinic 10/12 w/easy bruising on hands, elbow, knees, thigh & injection sites & extended menses w/heavy bleeding x 3 days. Dx at that time w/thrombocytopenic purpura. Admitted 10/13-10/18/2007 then medevaced home for additional outpatient treatment. In hospital tx w/steroids & plts waxed & waned during treatment. Upon return to US, treated by hematologist at university near company office then transferred care to hematologist near patient''s home in another state for continued f/u. FINAL DX: Thrombocytopenic purpura.


VAERS ID: 294547 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Female  
Location: Unknown  
Vaccinated:2007-02-12
Onset:2007-03-01
   Days after vaccination:17
Submitted: 2007-10-25
   Days after onset:237
Entered: 2007-10-27
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Abdominal pain, Endoscopy normal, Fatigue, Grip strength decreased, Nausea
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness:
Preexisting Conditions: None
Allergies:
Diagnostic Lab Data: endoscopy - negative
CDC Split Type: WAES0710USA04326

Write-up: Information has been received from a physician concerning a 12 year old female with no known allergies and no pertinent medical history who on 15-DEC-2006 was vaccinated intramuscularly with a first 0.5 mL dose of Gardasil. On 12-FEB-2007 the patient was vaccinated intramuscularly with a second 0.5 mL dose of Gardasil. There was no concomitant medication. Since March 2007, the patient experienced debilitating fatigue. The patient was unable to attend school and could barely get out of bed. The patient also experienced weakened hand grip, abdominal pain and nausea. A gastrointestinal work-up, including endoscopy was negative. On 14-JUN-2007 the patient was vaccinated intramuscularly with a third 0.5 mL dose of Gardasil. The physician reported that the patient''s symptoms worsened after the third dose of Gardasil. As of 22-OCT-2007 the patient''s debilitating fatigue, weakened hand grip, abdominal pain and nausea persisted. Debilitating fatigue, weakened hand grip, abdominal pain and nausea were considered to be disabling by the reporting physician. Additional information is not expected.


VAERS ID: 294632 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-10-26
Entered: 2007-10-29
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Blood glucose increased, Type 1 diabetes mellitus
SMQs:, Hyperglycaemia/new onset diabetes mellitus (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: YASMIN
Current Illness: Graves'' disease
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: diagnostic laboratory - diabetes; blood glucose $g500
CDC Split Type: WAES0710USA04650

Write-up: Information has been received from a nurse practitioner concerning her 25 year old daughter with Graves'' disease (onset age 13) and no known allergies, who on unknown dates was vaccinated IM, with the first and second dose, 0.5 ml, of Gardasil (lot # not provided). Concomitant therapy included drospirenone (+) ethinyl estradiol (YASMIN). One month after the second vaccination was administered, her daughter required a visit to the emergency room (details not specified). She was found to have a blood pressure glucose of over 500 (unit not specified), and was diagnosed with Type I diabetes. Insulin was administered as treatment, and she was hospitalized for 1 week. At the time of this report, her daughter had not recovered. The nurse practitioner considered Type I Diabetes to be immediately life-threatening, disabling/incapacitating and also an other important medical event. Additional information has been requested.


VAERS ID: 294633 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Female  
Location: California  
Vaccinated:2007-08-29
Onset:2007-09-28
   Days after vaccination:30
Submitted: 2007-10-26
   Days after onset:28
Entered: 2007-10-29
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1060U / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Acute lymphocytic leukaemia
SMQs:, Haematological malignant tumours (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 16 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: None. PMH: none. NKDA
Allergies:
Diagnostic Lab Data: diagnostic laboratory 09/28?/07. Labs and Diagnostics: CBC with WBC 91,600, platelets 42,000, bands 916, lymphs 22,900, monos 1832, eos 0.0, blasts 62,288, nucleated RBCs 916. BUN 30. bili total 1.3. AST 73. ALT 25. Labs and Diagnostics: CBC with WBCs 34 up to 53.8 and down to 0.4. Hgb 11.8, Hct 34, platelets 33K. AST 89. Bone marrow Bx CMV IgG Ab (+). LDH 2602. CXR WNL. Abd X-ray WNL. CMV IgG (+) at 28, IgM (-). CSF WNL.
CDC Split Type: WAES0710USA04762

Write-up: Information has been received from a physician, via a company representative, concerning an 11 year old female patient with no known allergies and no pertinent medical history, who on 29-JUL-2007 was vaccinated with a dose of Gardasil (lot #658556/1060U). The physician noted that the patient was healthy at the time of vaccination, and no other vaccines were administered. On 28-SEP-2007, the patient had unspecified blood work drawn and was diagnosed with "acute lymphocytic leukemia (ALL) Pre-B cell." The patient visited the hospital, but it was unknown if she was hospitalized. At the time of this report, the patient had not recovered. The physician considered ALL B-cell leukemia be immediately life-threatening. Additional information has been requested. 08/13/2008 Vax rec and labs received from PCP. Labs c/w acute leukemia. Referred to regional med ctr. 8/28/08 MR received for DOS 9/29-10/15/2007 with DX: Acute Lymphblastic Leukemia. Pt presented with 2 week hx of bruising and hematoma formation on sacral area, knees, groin. Labs concerning for Leukemia done by PCP, sent to ER for eval and tx. PE (+) for large hematomas on lower extremities and groin. Bone marrow bx c/w leukemia. Broviac cath placed. Hepatosplenomegaly on exam with high LDH. Chemo initiated on 104/07 completed on day 12. Required platelet transfusions. D/C 10/15/07 to f/u as outpt.


VAERS ID: 294699 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: New Jersey  
Vaccinated:2007-08-02
Onset:2007-08-02
   Days after vaccination:0
Submitted: 2007-10-26
   Days after onset:85
Entered: 2007-10-29
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0930U / 1 LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U2386BA / 1 LA / UN

Administered by: Private       Purchased by: Private
Symptoms: Loss of consciousness
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions: No
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: passed out briefly 3-5 minutes after receiving the shots. 10/31/2007 MR received for OVs 8/2/07 and 10/8/07. After receiving Menactra and Gardasil 8/2/07 pt passed out in reception area. Regained consciousness after a few seconds. Assessment: Postural Hypotension. Increased fluids advised. After 2nd Gardasil 10/8/07 pt felt dizzy and passed out. ? Vagal effect or hypoglycemia. Pt was seen having jerking movements when down. 3/13/09 Additional records received from PCP. OV 11/16/07 for college PE. Parent refused diagnostic tests since pt has been fine since syncopal episodes. Playing college soccer. 8/1/08 pt was running and felt tightness in chest and SOB. In office felt faint and dizzy, color pale, skin clammy. PE with RRR and clear lungs. Assess: R/O EIB. Syncope. OC 9/5/08 for eczema flair. Assess: Atopic dermatitis. Normal exam 3/4/09


VAERS ID: 294859 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Utah  
Vaccinated:2007-10-29
Onset:2007-10-29
   Days after vaccination:0
Submitted: 2007-10-30
   Days after onset:1
Entered: 2007-10-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LA / IM
HEPA: HEP A (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LA / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 LA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Convulsion, Dizziness, Dyskinesia, Foaming at mouth, Hyperhidrosis, Mydriasis, Nausea, Respiratory arrest, Syncope, Tongue discolouration, Unresponsive to stimuli
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (narrow), Dyskinesia (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: none~ ()~~0.00~In Patient|none~ ()~~0.00~In Sibling
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient was to receive 6 vaccinations on her visit, of which Gardasil was one. She received the Gardasil, a Hep B, and a Hep A in her left arm. As soon as the nurse gave the third injection, patient slumped over as if she had fainted. There had been no indication that she was about to faint. When I went to support her head, her eyes were wide open, pupils dilated. She was non responsive. Her feet and hands contorted, her tongue turned white, she started to foam at the mouth and she stopped breathing. The seizure lasted $g 2 minutes. This is a very healthy athlete with no seizure history. While being transported to the hospital, she experienced 2 more syncopal episodes without seizure, but accompanied by dizziness, nausea, and sweating. All tests (urine, blood) run at the ER were normal. After 6 hours she was released and has experienced no further incidents.


VAERS ID: 295176 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-10-31
Entered: 2007-11-01
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 2 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Dizziness, Gait disturbance, Hypoaesthesia, Pain in extremity
SMQs:, Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Vestibular disorders (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Doryx
Current Illness: Acne
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Unknown
CDC Split Type: WAES0710USA05676

Write-up: Information has been received from a physician, concerning her relative, a "15 or 16" year old female student with acne, who on an unknown date was vaccinated with the second dose of Gardasil (lot # not provided). Concomitant therapy included doxycycline byclate (DORYX). Following the vaccination, the student experienced arm pain, lightheadedness, generalized body numbness and a shuffling gait. The student also planned to see her family physician. At the time of this report, the student had not recovered from the events. The physician considered the events to be disabling, as the student had missed time in school. Additional information has been requested.


VAERS ID: 295191 (history)  
Form: Version 1.0  
Age: 15.0  
Sex: Female  
Location: California  
Vaccinated:2007-08-08
Onset:2007-08-08
   Days after vaccination:0
Submitted: 2007-11-01
   Days after onset:85
Entered: 2007-11-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0927U / UNK RA / ID
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U2232AA / UNK LA / ID
TDAP: TDAP (ADACEL) / SANOFI PASTEUR C2771AA / UNK LA / ID

Administered by: Unknown       Purchased by: Unknown
Symptoms: Headache, Muscular weakness, Paraesthesia
SMQs:, Rhabdomyolysis/myopathy (broad), Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: 10:30-11:00AM
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: LABS: CBC & chemistry WNL. MRI brain & spine WNL. CSF: glucose 49, protein 40, WBC 0, RBC 0. Blood & csf culture neg.
CDC Split Type:

Write-up: TEENAGER RECIEVED MENACTRA VACCINE ON 8/8/2007. PER PARENT REPORT IN ABOUT 12 HRS SHE DEVELOPED TINGLING IN FINGERS, HEADACHE AND WEAKNESS IN EXTREMITIES. ADMITTED TO HOSPITAL FOR GUILLAIN-BARRE SYNDROME. 11/16/07 Reviewed hospital medical records which reveal paitent experienced LE paralysis & paresthesias day after vax. Admitted 8/9-8/12/2007. Intensivist consult done in ER & dx as probably early GBS. Paralysis resolved on admit. Tx w/IVIG but patient developed high fever & tachycardia & IVIG was d/c''d. Then developed bradycardia which resolved by next day. Neuro consults x 2 done & neither agreed w/GBS dx. FINAL DX: acute paralysis of LE''s, resolved; reaction to IVIG, resolved; fever, resolved; bradycardia, resolved.


VAERS ID: 295488 (history)  
Form: Version 1.0  
Age: 25.0  
Sex: Female  
Location: New York  
Vaccinated:2007-10-24
Onset:2007-10-24
   Days after vaccination:0
Submitted: 2007-11-02
   Days after onset:9
Entered: 2007-11-05
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1062U / 1 UN / IM

Administered by: Other       Purchased by: Other
Symptoms: Anaphylactic reaction, Herpes simplex serology positive, Rash
SMQs:, Anaphylactic reaction (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ZOVIRAX; TRINESSA
Current Illness:
Preexisting Conditions: Unknown
Allergies:
Diagnostic Lab Data: diagnostic laboratory - positive herpes antibody
CDC Split Type: WAES0710USA05654

Write-up: Information has been received from a physician concerning a 25 year old female who on 24-OCT-2007 was vaccinated IM with the first dose of Gardasil (Lot #658560/1062U). Concomitant therapy included ethinyl estradiol/norgetimate (TRINESSA), acyclovir (ZOVIRAX) and influenza virus vaccine (unspecified). On 24-OCT-2007 the patient experienced anaphylaxis and rash 5 minutes after vaccination. Subsequently, the patient recovered from anaphylaxis and rash after being treated with 2 shots of Decadron and Benadryl. The physician considered these events to be life threatening. Additional information has been requested.


VAERS ID: 295507 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Female  
Location: Texas  
Vaccinated:2007-07-24
Onset:2007-08-07
   Days after vaccination:14
Submitted: 2007-08-30
   Days after onset:23
Entered: 2007-11-05
   Days after submission:67
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1447F / 1 UN / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR U2139AA / 1 UN / IM

Administered by: Private       Purchased by: Public
Symptoms: Ataxia, Azotaemia, Blood creatinine increased, Blood urea increased, Diplopia, Leukoencephalomyelitis, Muscular weakness, Nuclear magnetic resonance imaging brain abnormal
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Demyelination (narrow), Ocular motility disorders (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: Hyperlipidemia, abnormal LFT''s, acanthosis, overweight. PMH: Fx forearm, allergies, possible LFT abnormalities. NKDA.
Allergies:
Diagnostic Lab Data: MRI brain - abnormal findings in mid brain and base of brain; Increased BUN/CR. Labs and Diagnostics: MRI brain markedly abnormal findings involving midbrain and base of the brain. CT brain unremarkable. Renal US normal. Barium swallow with no penetration or aspiration. Admission CBC unremarkable. CMP with normal BUN and Creatinine with elevations beginning 8/16/07: BUN 20-57, Creatinine 1.8-3.8. Serum glucose elevations began 8/17/07. CSF with (+) RBCs with (+) oligoclonal bands. CSF MBP 7.76. CSF culture (-). No fungi in CSF. CSF HSV (-).Phytanic and Pristanic Acids WNL. Urine creatinine 52. UA with 1+ bacteria. UC (+) for Gram - bacillus and staph species. Tox screen (-).
CDC Split Type: TX0791

Write-up: Pt presented to the clinic on 8/13/07 with 1 week history of diplopia, ataxia, and weakness of extremities R$gL. Pt was admitted to hospital on 8/14 and dx with acute disseminated encephalomyelitis and azotemia. Pt was treated with a 5 day course of Solumedrol and Prednisone taper started with improvement in all sx''s except diplopia. 12/26/2007 MR received for DOS 8/14-24/2007. No formal D/C DX noted but following diagnostic studies DX of ADEM is proposed. Child presented to ER with 6 day hx of double vision, 4 day hx of unsteady gait, extremity weakness (R$gL) and abnormal eye movements noted by dad. Pt began running into things and falling while walking. Weakness, pain and unsteady gait have worsened. PE (+) for decreased strength upper & lower extremities, 1 beat clonus bilat, CN III palsy, R exotropia. Neurologic sequelae: Pt became more encephalopathic during admission (ataxia and III CN palsy) so transfered to PICU. Pt developed deteriorating renal function/azotemia which worsened after CT contrast. Txd with IV and po steroids. Discharged on day 10 in stable condition with aspiration precautions. 12/28/2007 Spoke with reporter who states only sequelae at this time is some occasional double vision when pt gets tired. Other sx such as ataxia, dysphagia and renal function are now resolved.


Result pages: prev   18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=27&VAX[]=HPV4&SERIOUS=ON


Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166